Design of novel screening environments for Mild Cognitive Impairment: giving priority to elicited speech and language abilities

被引:2
|
作者
Segkouli, Sofia [1 ,2 ]
Paliokas, Ioannis [1 ]
Tzovaras, Dimitrios [1 ]
Giakoumis, Dimitrios [1 ]
Karagiannidis, Charalampos [2 ]
机构
[1] Ctr Res & Technol Hellas CERTH, Inst Informat Technol, Thessaloniki, Greece
[2] Univ Thessaly, Dept Special Educ, Volos, Greece
关键词
component; Mild Cognitive Impairment; Screening batteries; Linguistic Test; Verbal fluency; ALZHEIMERS-DISEASE; PERFORMANCE; MCI;
D O I
10.4108/icst.pervasivehealth.2015.258945
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Recent cognitive decline screening batteries have highlighted the importance of language deficits related to semantic knowledge breakdown to reveal the incipient dementia. This paper proposes the introduction of novel enriched linguistic tests and examines the hypothesis that language can be a sensitive cognitive measure for Mild Cognitive Impairment (MCI). A group of MCI and healthy elderly were administered a set of proposed linguistic tests. Performance measures were made on both groups to indicate that concrete verbal production deficits such as impaired verb fluency can distinguish the MCI from normal aging. In addition, it was found that even in cases where the MCI subjects preserved scores, language tests took significantly more time compared to healthy controls. These findings indicate that language could be a sensitive cognitive marker in preclinical stages of MCI.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 37 条
  • [31] Survey Results of Speech-Language Pathologists Working With Cognitive-Communication Disorders: Improving Practices for Mild Cognitive Impairment and Early-Stage Dementia From Alzheimer's Disease
    Lanzi, Alyssa M.
    Saylor, Anna K.
    Cohen, Matthew L.
    AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2022, 31 (04) : 1653 - 1671
  • [32] Photo-Realistic Interactive Virtual Environments for Neurorehabilitation in Mild Cognitive Impairment (NeuroVRehab.PT): A Participatory Design and Proof-of-Concept Study
    Ferreira-Brito, Filipa
    Alves, Sergio
    Santos, Osvaldo
    Guerreiro, Tiago
    Caneiras, Catia
    Carrico, Luis
    Verdelho, Ana
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 18
  • [33] Novel duplication on chromosome 16 (q12.1-q21) associated with behavioral disorder, mild cognitive impairment, speech delay, and dysmorphic features: case report
    Odak, Ljubica
    Barisic, Ingeborg
    Pohovski, Leona Morozin
    Riegel, Mariluce
    Schinzel, Albert
    CROATIAN MEDICAL JOURNAL, 2011, 52 (03) : 415 - 422
  • [34] Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?
    Zygouris, Stelios
    Iliadou, Paraskevi
    Lazarou, Eftychia
    Giakoumis, Dimitrios
    Votis, Konstantinos
    Alexiadis, Anastasios
    Triantafyllidis, Andreas
    Segkouli, Sofia
    Tzovaras, Dimitrios
    Tsiatsos, Thrasyvoulos
    Papagianopoulos, Sotirios
    Tsolaki, Magda
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 405 - 412
  • [35] Validation of a Novel Computerized Self-Administered Memory-Screening Test With Automated Reporting (SAMSTAR) in Patients With Mild Cognitive Impairment and Normal Control Participants: A Randomized, Crossover, Controlled Study
    Morrison, Randall
    Pei, Huiling
    Novak, Gerald
    Kaufer, Daniel
    Welsh-Bohmer, Kathleen
    Ruhmel, Stephen
    Narayan, Vaibhav A.
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S345 - S346
  • [36] A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial
    Kim, Ko Woon
    Wang, Qi
    Koo, Se Hee
    Shin, Byoung-Soo
    TRIALS, 2022, 23 (01)
  • [37] A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial
    Ko Woon Kim
    Qi Wang
    Se Hee Koo
    Byoung-Soo Shin
    Trials, 23